Sonoma Pharmaceuticals (SNOA) announced the U.S. retail launch of its advanced HOCl-based burn relief hydrogel in CVS (CVS) and Walmart (WMT) stores nationwide. The hydrogel is indicated for the management of minor burns and skin irritations. This launch represents Sonoma’s first large-scale consumer-focused burn relief product, building on the Company’s established presence in professional healthcare settings, where its HOCl-based solutions have long been used in advanced wound and burn care protocols. Sonoma previously demonstrated its ability to translate clinically proven technologies into scalable consumer offerings through the launch of its diaper rash hydrogel in mass retail in 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNOA:
